| Dr David R Adin, DO | |
|
2381 38th St, Astoria, NY 11105-1909 | |
| (718) 777-1790 | |
| (718) 777-0339 |
| Full Name | Dr David R Adin |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 24 Years |
| Location | 2381 38th St, Astoria, New York |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134117211 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 224928 (New York) | Secondary |
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | 224928 (New York) | Primary |
| Entity Name | Central Jersey Medical Center Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932974250 PECOS PAC ID: 1456301241 Enrollment ID: O20050712000392 |
News Archive
A study featured in this month's edition of Gynecologic Oncology examines the challenges associated with the administration of intra-abdominal chemotherapy, also known as intraperitoneal (IP) chemotherapy.
A record 47% year-over-year sales increase for Q1, 2011 compared to the same period in 2010 was announced today by Centinel Spine, Inc., innovator and a market leader in the Integrated Interbody Fusion™ spine medical device space.
Alexza Pharmaceuticals, Inc. announced today that it has established a collaboration with Biovail Laboratories International SRL, a subsidiary of Biovail Corporation, to develop and commercialize AZ-004 (Staccato® loxapine) in the U.S. and Canada. AZ-004 is Alexza's lead program, based on the company's proprietary technology, the Staccato system. Alexza submitted its New Drug Application (NDA) for Staccato loxapine in December 2009. Alexza is seeking regulatory approval to market AZ-004, an inhalation product candidate developed for the rapid treatment of agitation in patients with schizophrenia or bipolar disorder.
Varian Medical Systems, Inc., the world's leading manufacturer of medical technology for treating cancer with radiotherapy and radiosurgery, will showcase its technology at two medical events in Asia during the month of March:
› Verified 6 days ago
| Entity Name | Nj Orthopedic Rehab And Pain Management Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205137528 PECOS PAC ID: 4284976978 Enrollment ID: O20190429002435 |
News Archive
A study featured in this month's edition of Gynecologic Oncology examines the challenges associated with the administration of intra-abdominal chemotherapy, also known as intraperitoneal (IP) chemotherapy.
A record 47% year-over-year sales increase for Q1, 2011 compared to the same period in 2010 was announced today by Centinel Spine, Inc., innovator and a market leader in the Integrated Interbody Fusion™ spine medical device space.
Alexza Pharmaceuticals, Inc. announced today that it has established a collaboration with Biovail Laboratories International SRL, a subsidiary of Biovail Corporation, to develop and commercialize AZ-004 (Staccato® loxapine) in the U.S. and Canada. AZ-004 is Alexza's lead program, based on the company's proprietary technology, the Staccato system. Alexza submitted its New Drug Application (NDA) for Staccato loxapine in December 2009. Alexza is seeking regulatory approval to market AZ-004, an inhalation product candidate developed for the rapid treatment of agitation in patients with schizophrenia or bipolar disorder.
Varian Medical Systems, Inc., the world's leading manufacturer of medical technology for treating cancer with radiotherapy and radiosurgery, will showcase its technology at two medical events in Asia during the month of March:
› Verified 6 days ago
| Entity Name | Ultima Sports And Spine, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811508641 PECOS PAC ID: 6901295526 Enrollment ID: O20211119000090 |
News Archive
A study featured in this month's edition of Gynecologic Oncology examines the challenges associated with the administration of intra-abdominal chemotherapy, also known as intraperitoneal (IP) chemotherapy.
A record 47% year-over-year sales increase for Q1, 2011 compared to the same period in 2010 was announced today by Centinel Spine, Inc., innovator and a market leader in the Integrated Interbody Fusion™ spine medical device space.
Alexza Pharmaceuticals, Inc. announced today that it has established a collaboration with Biovail Laboratories International SRL, a subsidiary of Biovail Corporation, to develop and commercialize AZ-004 (Staccato® loxapine) in the U.S. and Canada. AZ-004 is Alexza's lead program, based on the company's proprietary technology, the Staccato system. Alexza submitted its New Drug Application (NDA) for Staccato loxapine in December 2009. Alexza is seeking regulatory approval to market AZ-004, an inhalation product candidate developed for the rapid treatment of agitation in patients with schizophrenia or bipolar disorder.
Varian Medical Systems, Inc., the world's leading manufacturer of medical technology for treating cancer with radiotherapy and radiosurgery, will showcase its technology at two medical events in Asia during the month of March:
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David R Adin, DO 2381 38th St, Astoria, NY 11105-1909 Ph: (718) 777-1790 | Dr David R Adin, DO 2381 38th St, Astoria, NY 11105-1909 Ph: (718) 777-1790 |
News Archive
A study featured in this month's edition of Gynecologic Oncology examines the challenges associated with the administration of intra-abdominal chemotherapy, also known as intraperitoneal (IP) chemotherapy.
A record 47% year-over-year sales increase for Q1, 2011 compared to the same period in 2010 was announced today by Centinel Spine, Inc., innovator and a market leader in the Integrated Interbody Fusion™ spine medical device space.
Alexza Pharmaceuticals, Inc. announced today that it has established a collaboration with Biovail Laboratories International SRL, a subsidiary of Biovail Corporation, to develop and commercialize AZ-004 (Staccato® loxapine) in the U.S. and Canada. AZ-004 is Alexza's lead program, based on the company's proprietary technology, the Staccato system. Alexza submitted its New Drug Application (NDA) for Staccato loxapine in December 2009. Alexza is seeking regulatory approval to market AZ-004, an inhalation product candidate developed for the rapid treatment of agitation in patients with schizophrenia or bipolar disorder.
Varian Medical Systems, Inc., the world's leading manufacturer of medical technology for treating cancer with radiotherapy and radiosurgery, will showcase its technology at two medical events in Asia during the month of March:
› Verified 6 days ago
Dr. Usama Khayyal, MD Pain Medicine Medicare: Medicare Enrolled Practice Location: 2936 30th Ave, Astoria, NY 11102 Phone: 347-396-5612 | |
Dr. Damian Joseph Martino, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 3272 Steinway St Ste B01, Astoria, NY 11103 Phone: 917-485-1905 Fax: 917-456-0437 | |
Yakov Perper, MD Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 25-03 27th Street, Astoria, NY 11102 Phone: 718-687-2010 Fax: 718-517-2410 |